CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. Prevention of skin cancer and reduction of keratotic skin lesions during ...

A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...

October 24, 2011 — In nonstraightforward bone marrow analysis, the presence of 30% or more CD34+ megakaryocytes is a strong indicator of megaloblastic anemia or a myeloid neoplasm, according to a ...

Engraftment kinetics in BM or PBSC transplantation (PBSCT) depends on the number and efficiency of stem cells in the graft. Currently, stem cell evaluation is performed by counting CD34+ cells.

Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461 Thirteen patients (MM, n = 7; NHL, n = 6) ...

Epoch-Making Breakthrough of the Stem-Cell Nutritional Supplementation CD34 Nu-Signals®, Currently Undergoing Rigorous Clinical Trials Conducted by Prestigious Medical Institutions to Validate Its ...

LOS ANGELES, CA / ACCESSWIRE / September 15, 2023 / Alzheimer's disease and dementia severity in the United States is escalating, posing a growing public health crisis. With an aging population, ...

CAMBRIDGE, Mass. & HAIFA, Israel--(BUSINESS WIRE)--Minovia Therapeutics, a clinical-stage company focused on the development of cell-based Mitochondrial Augmentation Technology (MAT) to treat ...

Polycythemia vera is the ultimate phenotypic consequence of the V617F mutation in Janus kinase 2 (encoded by JAK2), but the extent to which this mutation influences the behavior of the involved CD34+ ...

CAMBRIDGE, Mass. & BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent ...